lupus Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Unknown (2)

Observational (2)

Assistance Publique - Hôpitaux de Paris (1)
Yale University (1)

No (1)
Yes (1)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadlupus

I am/have/hadpolymyositis

I am/have/hadautoimmune disease

I am/have/hadarthritis

I am/have/hadankylosing spondylitis

I am/have/hadprogressive systemic sclerosis

I am/have/hadraynaud's syndrome

I am/have/hadbehcet's disease

I am/have/hadbehcet's syndrome

I am/have/hadrheumatism

I am/have/hadpolymyalgia

I am/have/hadsjogren's syndrome

I am/have/hadpsoriatic arthritis

I am/have/hadconnective tissue disease

I am/have/hadvasculitis

I am/have/hadsarcoidosis

I am/have/hadchest ct

I am/have/hadadult onset still's disease

I am/have/hadundifferentiated connective tissue disease

I am/have/hadpulmonary involvement

added new label for I am/have/had

more

I am looking for

I am looking forcorticosteroids

I am looking forcyclophosphamide

I am looking forimmunosuppressive agents

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

For Seniors
For adults
Recruiting in 1000s
Observational Study
all
Dermatology
Recruiting

Rheumatology Patient Registry and Biorepository

To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.

skin disease

ankylosing spondylitis

scleroderma

polymyalgia rheumatica

arthritis

0 views
19 Feb, 2024

For Seniors
For adults
Recruiting in 10s
Observational Study
all
Dermatology
Recruiting

MPA AUC Monitoring in Patients Receiving MMF for Diffuse Cutaneous or Pulmonary Involvement in Systemic Sclerosis

To define a target value of AUC MPA to improve the modified Rodnan score and / or respiratory impairment (DLCO or FVC) at one year in patients receiving MMF for the treatment of diffuse cutaneous or interstitial lung damage of systemic sclerosis.

progressive systemic sclerosis

cyclophosphamide

skin sclerosis

scleroderma

raynaud disease

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.